Pioneering mRNA technology
Woolpert has been engaged to develop the architecture and interior design for the Australian production facility for one of the world’s leading pharmaceutical companies.
Client
Moderna
Location
Monash, VIC, Australia
Size
10,300 sqm
We are proud to be designing this world leading centre for innovation which will be the first place in the southern hemisphere to manufacture mRNA vaccines, after the Victorian Government reached an in-principle agreement with the Commonwealth Government and Moderna.
Phase 1 has a $500 Million construction budget.
The building design building block is based on Moderna’s bespoke manufacturing process, endorsed by global regulatory authorities.
Phase 1 has a $500 Million construction budget.
The building design building block is based on Moderna’s bespoke manufacturing process, endorsed by global regulatory authorities.
The best in its class; this initiative will provide vaccine security, ensuring manufacturing can be contracted locally to avoid global supply chain issues and creating a more robust defence against future pandemics.
Woolpert is thrilled to be the local architectural partner for the new Moderna pharmaceutical production facility in Victoria.
This project ties in perfectly with Woolpert’s expertise of designing and building intricate, inspiring and bespoke Mission Critical Facilities.
Woolpert is thrilled to be the local architectural partner for the new Moderna pharmaceutical production facility in Victoria.
This project ties in perfectly with Woolpert’s expertise of designing and building intricate, inspiring and bespoke Mission Critical Facilities.
